News
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...
After playing teenagers together on screen, Sarah Michelle Gellar and Allyson Hannigan open up to PEOPLE about raising ...
A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...
Explore more
Belrestotug plus dostarlimab showed no progression-free survival benefit in NSCLC, leading GSK and iTeos to discontinue all ...
16h
Zacks Investment Research on MSNGSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugGSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...
The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...
Health-care companies fell amid concerns about increased regulation and upheaval in the sector. UnitedHealth Group continued its retreat after the abrupt departure of its chief executive.
GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion ...
Teos Therapeutics downgraded to Hold after belrestotug failure and GSK deal ending. Read my updated analysis on ITOS stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results